People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Pharmaceuticals, Other Health Care, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Osteal Therapeutics, Inc. | — | Pharmaceuticals | Series C | $127.5M | $87.0M | 2021 |
| Urotronic, Inc. | — | Other Health Care | Series B | $38.5M | $253.7M | 2018 |
| GIE Medical, Inc. | — | Healthtech | Series A | $18.0M | $34.0M | 2023 |
Rushu Luo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rushu Luo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hui Hu | 2 | 4 |
| Lixiao Wang | 2 | 4 |
| David Perry | 1 | 11 |
| David Thompson | 1 | 10 |
| Renee Ryan | 1 | 6 |
| Douglas Kohrs | 1 | 4 |
| Jeff Thomas | 1 | 4 |
| Yuriy Prilutskiy | 1 | 3 |
| Doug Kohrs | 1 | 3 |
| Tan Ching | 1 | 2 |
| Martin Sands | 1 | 2 |
| Ouyang Xiangyu | 1 | 2 |
| Biren Mehta | 1 | 2 |
| David Cash | 1 | 2 |
| Noam Krantz | 1 | 2 |
| Jude Paganelli | 1 | 2 |
| Junfeng Wang | 1 | 1 |
| Judson Cooper | 1 | 1 |
| Brian De Beaubien | 1 | 1 |
| Erik Oros | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.